 SOUTH SAN FRANCISCO, Calif., March 23, 2021 GLOBE NEWSWIRE -- UNITY Biotechnology, Inc. UNITY NASDAQ:UBX, a biotechnology company developing therapeutics to slow, halt, or reverse diseases of aging, today reported financial results for the fourth quarter and full year ended December 31, 2020. 